Table of Contents
<< Previous Issue | Nov 2016 (Vol: 2016, Issue: 11) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Astellas Advances Oncology Strategy with US$1.4 B Ganymed Purchase
-
Medivir Prioritises R&D by Divesting Mature Biophausia Portfolio
- Section: Research & Development
-
Takeda Partners with Crescendo Biologics for Humabody®-based Oncology Therapeutics